ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Osteoarthritis"

  • Abstract Number: 2668 • 2013 ACR/ARHP Annual Meeting

    A Randomized, Double-Blind, Dose Ranging Study Comparing FX006, An Intra-Articular (IA) Sustained-Release Formulation Of Triamcinolone Acetonide (TCA), To An Approved Injectable Suspension Of TCA In Patients With Osteoarthritis (OA) Of The Knee

    Neil Bodick1, Joelle Lufkin1, Christina Willwerth1, Pierre Lachance2, Gregory Jasey3, Anil Gupta4, Anthony Chris5, Marc Russo6, Michael O'Mahony7, Sam Henein8, Louise Murdoch9, Ferdinandus de Looze10, David Hunter11 and Michael Clayman1, 1Flexion Therapeutics, Burlington, MA, 2Clinique St-Louis (Recherche) Inc, Quebec, QC, Canada, 3North Walkerville Orthopaedic Associates, Windsor, ON, Canada, 4Anil K. Gupta Medicine Professional Corporation, Toronto, ON, Canada, 5Aim Health Group, Waterloo, ON, Canada, 6Hunter Clinical Research, Broadmeadow, Australia, 7London Road Diagnostic Clinic and Medical Centre, Sarnia, ON, Canada, 8SKDS Research Inc., Newmarket, ON, Canada, 9Emeritus Research, Malvern East, Australia, 10AusTrials Pty Limited, Sherwood, Australia, 11Royal North Shore Hospital, St. Leonards, Australia

    Background/Purpose: FX006 is a novel sustained-release formulation of TCA in poly(lactic-co-glycolic) acid microspheres intended to maintain therapeutic concentrations in the joint  up to 3 months…
  • Abstract Number: 1719 • 2013 ACR/ARHP Annual Meeting

    High Reliability Was Found for Ultrasound Scoring of Osteophytes in Patients With Hand Osteoarthritis Using An Atlas As Reference; An Omeract Initiative

    Hilde B. Hammer1, Alexander Mathiessen1, Annamaria Iagnocco2, Emilio Filippucci3, Frédérique Gandjbakhch4, Marion C. Kortekaas5, Ingrid Möller6, Esperanza Naredo7, Richard J. Wakefield8, Philippe Aegerter9 and Maria-Antonietta d'Agostino10, 1Dept of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Sapienza University of Rome, Rome, Italy, 3Clinica Reumatologica, Università Politecnica delle Marche, Ancona, Italy, 4Department of Rheumatology, APHP, Pitié Salpétrière Hospital, Universite Paris 6, Paris, France, 5Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 6Instituto Poal de Reumatologia, Barcelona, Spain, 7Rheumatology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain, 8NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds & Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 9Epidemiology, Versailles-Saint Quentin en Yvelines University- APHP, Ambroise-Paré Hospital,, Boulogne-Billancourt,, France, 10Rheumatology, Ambroise Paré Hospital, and Versailles Saint Quentin en Yvelines University, Boulogne-Billancourt, France

    Background/Purpose: Ultrasound (US) is a sensitive method for detecting osteophytes (OP) in hand osteoarthritis (HOA).  To improve the reliability of scoring OP, an US atlas…
  • Abstract Number: 86 • 2013 ACR/ARHP Annual Meeting

    The Role Of Meniscal Cells In Osteoarthritis Calcification

    Andrea Roberts1, David Mauerhan2 and Yubo Sun2, 1Orthopedic Biology Research, Carolinas Healthcare System, Charlotte, NC, 2Orthopaedic Surgery, Carolinas Medical Center, Charlotte, NC

    Background/Purpose: Osteoarthritis (OA) is a disease that is characterized by the breakdown or loss of articular cartilage due to biomechanical and biochemical changes in the…
  • Abstract Number: 2315 • 2013 ACR/ARHP Annual Meeting

    Reducing The Need For Total Knee Arthroplasty:  The Experience Of a Multidisciplinary Osteoarthritis Clinic

    Caroline Jones1, Angelo Papachristos1 and Laurence A. Rubin2, 1Physiotherapy, St Michael's Hospital, Toronto, ON, Canada, 2Rheumatology, St. Michael Hospital, Toronto, ON, Canada

    Background/Purpose: St. Michael’s Hospital (SMH) is a tertiary care facility located in Toronto, serving a diverse social, economic and cultural urban population. In 2008, a…
  • Abstract Number: 1694 • 2013 ACR/ARHP Annual Meeting

    A Randomised Trial Of A Brace For Patellofemoral Osteoarthritis Targeting Knee Pain and Bone Marrow Lesions

    David T. Felson1,2, Matthew J. Parkes1, Andrew D. Gait3, Elizabeth J. Marjanovic3, Mark Lunt4, Charles E. Hutchinson5, Laura Forsythe6, Timothy F. Cootes3 and Michael Callaghan1, 1Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, University of Manchester, Manchester, United Kingdom, 2Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 3Imaging Sciences, School of Cancer & Enabling Sciences, University of Manchester, Manchester, United Kingdom, 4Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, United Kingdom, 5Warwick Medical School, University of Warwick, Coventry, United Kingdom, 6Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, United Kingdom

    Background/Purpose: Patellofemoral (PF) braces have been shown to increase contract area in this joint, decreasing focal stress  and may also correct patellar malalignment. Bone marrow…
  • Abstract Number: 84 • 2013 ACR/ARHP Annual Meeting

    New Formulation With Potential To Prevent and Treat Osteoporosis and Osteoarthritis

    A. Torrent1, E. Montell2, J. Vergés1, P. Dalmau3, R. Ruhí3, M.C. Carceller4, A. Blanco4, M.C. Terencio4, M.L. Ferrándiz4 and M.J. Alcaraz5, 1Pre-Clinical R&D Area, Pharmascience Division, BIOIBERICA S.A., Barcelona, Spain, 2Pharmascience Division, BIOIBERICA S.A., Barcelona, Spain, 3Technological Extraction Dept, BIOIBERICA S.A., Palafolls, Spain, 4Department of Pharmacology and IDM, University of Valencia, Burjassot, Spain, 5University of Valencia, Burjasot, Valencia, Spain

    Background/Purpose: Osteoarthritis (OA) is a multidimensional disease that affects all anatomical joint structures, particularly cartilage, synovium and subchondral bone. In turn, osteoporosis (OP) is a…
  • Abstract Number: 2479 • 2012 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis Does Not Increase Risk of Short Term Total Knee Replacement (TKR) Adverse Events (AE)

    Zachary J. LoVerde1, Lisa A. Mandl2, Beverly K. Johnson2, Mark P. Figgie3, Friedrich Boettner4 and Susan M. Goodman2, 1New York Medical College, Valhalla, NY, 2Rheumatology, Hospital for Special Surgery, New York, NY, 3Orthopedics, Hospital for Special Surgery, New York, NY, 4Orthopaedics, Hospital for Special Surgery, New York, NY

    Background/Purpose: TKR is commonly performed for rheumatoid arthritis (RA) and osteoarthritis (OA). Historically, RA patients were at higher risk of post-operative AEs. The purpose of…
  • Abstract Number: 1109 • 2012 ACR/ARHP Annual Meeting

    Effects of Strontium Ranelate On Hand Osteoarthritis – Analysis of Data From the Sekoia Trial

    E. Maheu1, C. Cadet2 and F. Berenbaum3, 1AP-HP, Saint-Antoine Hospital, Rheumatology Department and DHU i2B, Paris, France, 2Rheumatology, Paris, France, 3Rheumatology, AP-HP St Antoine Hospital, Paris, France

    Background/Purpose:  Strontium ranelate (SrRan) has shown the ability to reduce radiological progression of knee osteoarthritis (OA) over 3 years. Patients with knee OA are also…
  • Abstract Number: 260 • 2012 ACR/ARHP Annual Meeting

    Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program

    Marc C. Hochberg1, Steven B. Abramson2, David S. Hungerford3, Edward McCarthy4, Eric P. Vignon5, Michael D. Smith6, Leslie Tive7, Kenneth M. Verburg6 and Christine R. West8, 1Department of Medicine, University of Maryland, Baltimore, MD, 2Dept of Rheumatology/Medicine, NYU Langone Medical Center, New York, NY, 3Department of Ortho Surgery, Johns Hopkins University, Baltimore, MD, 4Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, 5Rheumatology 2B, Centre Hospitalier, Pierre Benite, France, 6Pfizer, Inc., Groton, CT, 7Arthritis, Pfizer Inc, New York, NY, 8Clinical Sciences, Pfizer, Williamston, MI

    Background/Purpose: Tanezumab (TNZ) has been shown to be efficacious for pain and function in patients with hip and knee osteoarthritis (OA). Unexpected reports of adverse…
  • Abstract Number: 2441 • 2012 ACR/ARHP Annual Meeting

    Readability and Suitability Assessment of Patient Education Materials in Rheumatic Diseases

    Rennie L. Rhee1, Joan Marie Von Feldt2, H. Ralph Schumacher3 and Peter A. Merkel4, 1Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Rheumatology, Univ of Pennsylvania/Philadelphia VAMC, Philadelphia, PA, 3Department of Medicine, University of Pennsylvania and VA Medical Center, Philadelphia, PA, 4University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Comprehension of health resources may be challenging for patients particularly those with limited health literacy. The objective of this study was to examine the…
  • Abstract Number: 1112 • 2012 ACR/ARHP Annual Meeting

    Patients with Erosive Osteoarthritis Have Less Extensive Synovitis Than Patients with Rheumatoid Arthritis On Histopathology

    Allen P. Anandarajah1, Stephen Kates2, Kate Burns3 and Ellen Giampoli4, 1Dept of Rheumatology, Univ of Rochester Medical Ctr, Rochester, NY, 2Orthopedic Surgery, University of Rochester Medical Center, Rochester, NY, 3Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, 4Pathology, University of Rochester Medical Ctr, Rochester, NY

    Background/Purpose: Patients with erosive osteoarthritis (EOA) often develop disfiguring deformities and associated decline in hand function.  We have previously demonstrated that synovitis was a common…
  • Abstract Number: 240 • 2012 ACR/ARHP Annual Meeting

    Degenerative Changes in Patients with Knee Pain: A Comparative Study Between Ultrasound and Conventional Radiology

    Santiago Ruta1, Erika Catay2, Javier Rosa2, David A. Navarta3, Ricardo Garcia-Monaco4 and Enrique R. Soriano5, 1Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 2Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 3Internal Medicine, Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 4Radiology and Imagenology Department, Hospital italiano de Buenos Aires, Buenos Aires, Argentina, 5Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina

    Background/Purpose: Knee osteoarthritis (OA) is one of the most common rheumatologic joint diseases and causes an important disability in the elderly population.  To date the…
  • Abstract Number: 2400 • 2012 ACR/ARHP Annual Meeting

    Hospital for Special Surgery Osteoarthritis Wellness Initiative:  the Impact of a Hospital-Based Exercise Program On Osteoarthritis

    Sandra Goldsmith1, Dana Friedman1, Linda Roberts1, Dana Sperber1 and Laura Robbins2, 1Public and Patient Education, Hospital for Special Surgery, New York, NY, 2Education & Academic Affairs, Hospital for Special Surgery, New York, NY

    Background/Purpose: The Centers for Disease Control and Prevention (CDC) reports that about 27 million adults were affected by osteoarthritis (OA) in 2005.  OA is characterized…
  • Abstract Number: 1114 • 2012 ACR/ARHP Annual Meeting

    Prevalence of Radiographic and Symptomatic Hip Osteoarthritis in an Urban US Population: The Framingham Osteoarthritis Study

    Katherine D. Linsenmeyer1, Ali Guermazi2, Kyu-Chan Kim1, David T. Felson3, Mary M. Clancy4 and Steven C. Vlad5, 1Internal Medicine, Boston Medical Center, Boston, MA, 2Radiology, Boston University, Boston, MA, 3Boston University, Boston, MA, 4School of Medicine, Boston University, Boston, MA, 5Clinical Epidemiology, Boston University, Boston, MA

    Background/Purpose: There are few studies of hip osteoarthritis (OA) in the United States and none in the last 35 years that have addressed the prevalence…
  • Abstract Number: 241 • 2012 ACR/ARHP Annual Meeting

    Excess Body Weight and 4-Year Function Outcomes: Comparison of African-Americans and Caucasians in the Osteoarthritis Initiative

    Carmelita J. Colbert1, Orit Almagor2, Joan S. Chmiel2, Jing Song3, Dorothy D. Dunlop3, Karen W. Hayes4 and Leena Sharma2, 1Department of Medicine, Division of Rheumatology, Northwestern University, Chicago, IL, 2Northwestern University, Chicago, IL, 3Northwestern University Feinberg School of Medicine, Chicago, IL, 4Department of Physical Therapy and Human Movement Sciences, Northwestern University, Chicago, IL

    Background/Purpose:   Given the heterogeneity of knee OA impact, it is important to identify persons at risk for poor outcome.  A better understanding of differences…
  • « Previous Page
  • 1
  • …
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology